Hisamitsu Pharmaceutical Co., Inc.

OTCPK:HTSU.Y Stock Report

Market Cap: US$8.2b

Hisamitsu Pharmaceutical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Kazue Nakatomi

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure11yrs
CEO ownershipn/a
Management average tenure2.3yrs
Board average tenure9yrs

Recent management updates

No updates

Recent updates

No updates

CEO

Kazue Nakatomi (53 yo)

11yrs
Tenure

Mr. Kazuhide Nakatomi, also known as Kazue, serves as Chief Executive Officer since May 2015, President since May 2015 & Representative Director since May 2007 at Hisamitsu Pharmaceutical Co. Inc. and serv...

Leadership Team

NamePositionTenureCompensationOwnership
Kazuhide Nakatomi
President11yrsno datano data
Naruhito Higo
Managing Exec. Officer & Head of Global Tech. Dev.2.3yrsno datano data
Nobuo Tsutsumi
Exe. Officer of Legal Affairs12yrsno data0%
$ 0
Hidenao Minami
Executive Officer of Public Relations2.3yrsno datano data
Kosuke Sugiyama
Senior MD & Exec. Officer of Human Resources & R&D and Corporate Strategy Planningless than a yearno datano data
Tetsuo Akiyama
Senior Managing Executive Officer2.3yrsno datano data
Kyu Saito
MD, Executive Officer & Directorno datano data0%
$ 0
Shinichi Murayama
Executive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Directorno datano data0%
$ 0
Mitsutoshi Tsuruta
Senior Executive Officer & Head of Sales & Marketing Division of RXno datano datano data
Masaya Okuno
Senior Executive Officer & Head of Sales & Marketing Division of OTCno datano datano data
Koji Takiyama
Exec. Officerless than a yearno data0%
$ 0
Katsuhiko Akiyama
Senior Executive Officer & Head of MN Business Development Office3.3yrsno datano data
2.3yrs
Average Tenure
59.5yo
Average Age

Experienced Management: HTSU.Y's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Kazuhide Nakatomi
President19yrsno datano data
Nobuo Tsutsumi
Exe. Officer of Legal Affairs12yrsno data0%
$ 0
Kyu Saito
MD, Executive Officer & Director13yrsno data0%
$ 0
Shinichi Murayama
Executive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Director12yrsno data0%
$ 0
Koji Takiyama
Exec. Officer5yrsno data0%
$ 0
Munehiko Hirano
Standing Corporate Auditor20yrsno data0%
$ 0
Nobuyuki Nakatomi
Chairman of Auditors18yrsno data0%
$ 0
Tetsugo Matuo
Part-Time Outside Independent Director6yrsno data0%
$ 0
Yuichiro Anzai
Part-Time Outside Independent Director6yrsno datano data
Kentaro Watanabe
Part Time Outside Corporate Auditor3yrsno datano data
Tamako Watanabe
Part-Time Outside Independent Director3yrsno datano data
Ryusuke Itakura
Part-Time Outside Corporate Auditor2yrsno datano data
9.0yrs
Average Tenure
59.5yo
Average Age

Experienced Board: HTSU.Y's board of directors are considered experienced (9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/26 13:23
End of Day Share Price 2026/05/12 00:00
Earnings2026/02/28
Annual Earnings2026/02/28

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hisamitsu Pharmaceutical Co., Inc. is covered by 10 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ritsuo WatanabeBofA Global Research
Hidemaru YamaguchiCitigroup Inc
Akitada IwasaDaiwa Securities Co. Ltd.